---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-458486"
form_type: "8-K"
ticker: "SCTX"
cik: "0001853921"
company_name: "Scribe Therapeutics, Inc."
filed_at: "2026-11-12T21:20:14+00:00"
generated_at: "2026-11-12T21:21:16.288995+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Scribe Therapeutics Q3 2026 net loss $9.9M ($0.68/sh); $174.2M cash funds operations into 1H 2029

## Summary
- Net loss $9.9M ($0.68 per basic and diluted share) vs $6.5M net loss in Q2 2026; R&D $8.3M, G&A $4.2M, collaboration revenue $1.6M.
- Cash, equivalents and marketable securities $174.2M at Sept 30, 2026 vs $43.0M at June 30, after ~$140.2M net IPO/private placement proceeds; runway into 1H 2029.
- STX-1150 Phase 1 in elevated LDL-C ongoing; safety, tolerability and LDL-C data from single ascending dose expected 1H 2027; NHP data showed >50% LDL-C cut at 0.75 mg/kg for two years.
- Expanded Sanofi collaboration to include ELXR epigenetic silencing technology, adding to XE gene editing and extending Sanofi's target nomination period; no financial terms disclosed.
- July 2026 IPO upsized and priced at high end; ~$155.5M gross proceeds including underwriters' option and concurrent Sanofi private placement at the IPO price.

## SEC filing metadata
- accession: 0001193125-26-458486
- form_type: 8-K
- ticker: SCTX
- cik: 0001853921
- company_name: Scribe Therapeutics, Inc.
- filed_at: 2026-11-12T21:20:14+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853921/000119312526458486/0001193125-26-458486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853921/000119312526458486/sctx-20261112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-458486
- JSON: https://secwatch.observer/filing/0001193125-26-458486.json
- Plain text: https://secwatch.observer/filing/0001193125-26-458486.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
